PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 211 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $142,000 | -58.7% | 19,851 | +37.7% | 0.02% | -44.1% |
| Q4 2019 | $344,000 | -25.4% | 14,411 | -15.3% | 0.03% | -37.0% |
| Q2 2019 | $461,000 | -21.9% | 17,010 | 0.0% | 0.05% | -21.7% |
| Q1 2019 | $590,000 | +77.7% | 17,010 | 0.0% | 0.07% | +56.8% |
| Q4 2018 | $332,000 | +3.1% | 17,010 | +40.5% | 0.04% | +15.8% |
| Q3 2018 | $322,000 | -32.6% | 12,110 | -4.3% | 0.04% | -36.7% |
| Q2 2018 | $478,000 | +18.6% | 12,650 | +2.6% | 0.06% | +15.4% |
| Q1 2018 | $403,000 | -32.8% | 12,330 | 0.0% | 0.05% | -20.0% |
| Q4 2017 | $600,000 | -46.8% | 12,330 | -40.9% | 0.06% | -49.2% |
| Q3 2017 | $1,128,000 | -3.8% | 20,880 | 0.0% | 0.13% | -3.8% |
| Q2 2017 | $1,173,000 | +53.3% | 20,880 | +7.0% | 0.13% | +49.4% |
| Q1 2017 | $765,000 | +74.7% | 19,510 | 0.0% | 0.09% | +67.9% |
| Q4 2016 | $438,000 | -22.1% | 19,510 | -21.1% | 0.05% | -23.2% |
| Q3 2016 | $562,000 | +7.5% | 24,740 | +11.7% | 0.07% | +3.0% |
| Q2 2016 | $523,000 | +34.8% | 22,150 | +16.5% | 0.07% | +34.0% |
| Q1 2016 | $388,000 | -40.3% | 19,020 | +11.1% | 0.05% | -34.2% |
| Q1 2015 | $650,000 | +28.2% | 17,114 | -4.4% | 0.08% | +24.6% |
| Q4 2014 | $507,000 | +11.9% | 17,910 | 0.0% | 0.06% | +10.9% |
| Q3 2014 | $453,000 | -10.1% | 17,910 | +3.8% | 0.06% | -14.1% |
| Q2 2014 | $504,000 | +12.8% | 17,260 | 0.0% | 0.06% | +6.7% |
| Q1 2014 | $447,000 | – | 17,260 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|